Actinium Pharmaceuticals, Inc. (ATNM) Insider Trading -- Recent Executive & Director Transactions

1 insiders reported 1 Form 4 transactions for Actinium Pharmaceuticals, Inc. (ATNM) over the past 18 months (most recent 2025-08-20). Recent activity: SETH SANDESH (Chief Executive Officer) Sell 120,900 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2025-08-20SETH SANDESHChief Executive OfficerSell120,900$206,739

Source: SEC Form 4 filings · as of 2025-08-20